| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |